272 related articles for article (PubMed ID: 29444979)
1. Irreversible inhibition of cytosolic thioredoxin reductase 1 as a mechanistic basis for anticancer therapy.
Stafford WC; Peng X; Olofsson MH; Zhang X; Luci DK; Lu L; Cheng Q; Trésaugues L; Dexheimer TS; Coussens NP; Augsten M; Ahlzén HM; Orwar O; Östman A; Stone-Elander S; Maloney DJ; Jadhav A; Simeonov A; Linder S; Arnér ESJ
Sci Transl Med; 2018 Feb; 10(428):. PubMed ID: 29444979
[TBL] [Abstract][Full Text] [Related]
2. Thioredoxin Reductase Inhibition for Cancer Therapy.
Gencheva R; Arnér ESJ
Annu Rev Pharmacol Toxicol; 2022 Jan; 62():177-196. PubMed ID: 34449246
[TBL] [Abstract][Full Text] [Related]
3. Methionine restriction exposes a targetable redox vulnerability of triple-negative breast cancer cells by inducing thioredoxin reductase.
Malin D; Lee Y; Chepikova O; Strekalova E; Carlson A; Cryns VL
Breast Cancer Res Treat; 2021 Dec; 190(3):373-387. PubMed ID: 34553295
[TBL] [Abstract][Full Text] [Related]
4. Induction of Oxidative Stress Through Inhibition of Thioredoxin Reductase 1 Is an Effective Therapeutic Approach for Hepatocellular Carcinoma.
Lee D; Xu IM; Chiu DK; Leibold J; Tse AP; Bao MH; Yuen VW; Chan CY; Lai RK; Chin DW; Chan DF; Cheung TT; Chok SH; Wong CM; Lowe SW; Ng IO; Wong CC
Hepatology; 2019 Apr; 69(4):1768-1786. PubMed ID: 30561826
[TBL] [Abstract][Full Text] [Related]
5. Substrate and inhibitor specificities differ between human cytosolic and mitochondrial thioredoxin reductases: Implications for development of specific inhibitors.
Rackham O; Shearwood AM; Thyer R; McNamara E; Davies SM; Callus BA; Miranda-Vizuete A; Berners-Price SJ; Cheng Q; Arnér ES; Filipovska A
Free Radic Biol Med; 2011 Mar; 50(6):689-99. PubMed ID: 21172426
[TBL] [Abstract][Full Text] [Related]
6. Mitochondrial thioredoxin reductase 2 is elevated in long-lived primate as well as rodent species and extends fly mean lifespan.
Pickering AM; Lehr M; Gendron CM; Pletcher SD; Miller RA
Aging Cell; 2017 Aug; 16(4):683-692. PubMed ID: 28474396
[TBL] [Abstract][Full Text] [Related]
7. Guiding bar motif of thioredoxin reductase 1 modulates enzymatic activity and inhibitor binding by communicating with the co-factor FAD and regulating the flexible C-terminal redox motif.
Shi W; Sun S; Liu H; Meng Y; Ren K; Wang G; Liu M; Wu J; Zhang Y; Huang H; Shi M; Xu W; Ma Q; Sun B; Xu J
Redox Biol; 2024 Apr; 70():103050. PubMed ID: 38277963
[TBL] [Abstract][Full Text] [Related]
8. Selenium-independent antioxidant and anti-inflammatory effects of thioredoxin reductase inhibition in alveolar macrophages.
Staples S; Wall SB; Li R; Tipple TE
Life Sci; 2020 Oct; 259():118285. PubMed ID: 32798556
[TBL] [Abstract][Full Text] [Related]
9. Estradiol regulates the thioredoxin antioxidant system in the mouse uterus.
Deroo BJ; Hewitt SC; Peddada SD; Korach KS
Endocrinology; 2004 Dec; 145(12):5485-92. PubMed ID: 15345672
[TBL] [Abstract][Full Text] [Related]
10. Auranofin-mediated inhibition of PI3K/AKT/mTOR axis and anticancer activity in non-small cell lung cancer cells.
Li H; Hu J; Wu S; Wang L; Cao X; Zhang X; Dai B; Cao M; Shao R; Zhang R; Majidi M; Ji L; Heymach JV; Wang M; Pan S; Minna J; Mehran RJ; Swisher SG; Roth JA; Fang B
Oncotarget; 2016 Jan; 7(3):3548-58. PubMed ID: 26657290
[TBL] [Abstract][Full Text] [Related]
11. Targeting the Selenoprotein Thioredoxin Reductase 1 for Anticancer Therapy.
Arnér ESJ
Adv Cancer Res; 2017; 136():139-151. PubMed ID: 29054416
[TBL] [Abstract][Full Text] [Related]
12. Cytoplasmic thioredoxin reductase is essential for embryogenesis but dispensable for cardiac development.
Jakupoglu C; Przemeck GK; Schneider M; Moreno SG; Mayr N; Hatzopoulos AK; de Angelis MH; Wurst W; Bornkamm GW; Brielmeier M; Conrad M
Mol Cell Biol; 2005 Mar; 25(5):1980-8. PubMed ID: 15713651
[TBL] [Abstract][Full Text] [Related]
13. Comprehensive chemical proteomics analyses reveal that the new TRi-1 and TRi-2 compounds are more specific thioredoxin reductase 1 inhibitors than auranofin.
Sabatier P; Beusch CM; Gencheva R; Cheng Q; Zubarev R; Arnér ESJ
Redox Biol; 2021 Nov; 48():102184. PubMed ID: 34788728
[TBL] [Abstract][Full Text] [Related]
14. Effect of selenium on thioredoxin reductase activity in Txnrd1 or Txnrd2 hemizygous mice.
Kiermayer C; Michalke B; Schmidt J; Brielmeier M
Biol Chem; 2007 Oct; 388(10):1091-7. PubMed ID: 17937623
[TBL] [Abstract][Full Text] [Related]
15. To inhibit TrxR1 is to inactivate STAT3-Inhibition of TrxR1 enzymatic function by STAT3 small molecule inhibitors.
Busker S; Page B; Arnér ESJ
Redox Biol; 2020 Sep; 36():101646. PubMed ID: 32863208
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of thioredoxin reductase 1 correlates with platinum-based chemotherapeutic induced tissue injury.
Cheng P; Liu H; Li Y; Pi P; Jiang Y; Zang S; Li X; Fu A; Ren X; Xu J; Holmgren A; Lu J
Biochem Pharmacol; 2020 May; 175():113873. PubMed ID: 32092292
[TBL] [Abstract][Full Text] [Related]
17. Loss of thioredoxin reductase 1 renders tumors highly susceptible to pharmacologic glutathione deprivation.
Mandal PK; Schneider M; Kölle P; Kuhlencordt P; Förster H; Beck H; Bornkamm GW; Conrad M
Cancer Res; 2010 Nov; 70(22):9505-14. PubMed ID: 21045148
[TBL] [Abstract][Full Text] [Related]
18. Selenium supplementation of lung epithelial cells enhances nuclear factor E2-related factor 2 (Nrf2) activation following thioredoxin reductase inhibition.
Tindell R; Wall SB; Li Q; Li R; Dunigan K; Wood R; Tipple TE
Redox Biol; 2018 Oct; 19():331-338. PubMed ID: 30212802
[TBL] [Abstract][Full Text] [Related]
19. Lysine oxidase exposes a dependency on the thioredoxin antioxidant pathway in triple-negative breast cancer cells.
Chepikova OE; Malin D; Strekalova E; Lukasheva EV; Zamyatnin AA; Cryns VL
Breast Cancer Res Treat; 2020 Oct; 183(3):549-564. PubMed ID: 32696316
[TBL] [Abstract][Full Text] [Related]
20. The production of reactive oxygen species enhanced with the reduction of menadione by active thioredoxin reductase.
Li J; Zuo X; Cheng P; Ren X; Sun S; Xu J; Holmgren A; Lu J
Metallomics; 2019 Sep; 11(9):1490-1497. PubMed ID: 31359011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
